Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness

Documenti analoghi

• BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer
  di: Lips, Esther H., et al.
  Pubblicazione: (2020)
• Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers
  di: Lips, E H, et al.
  Pubblicazione: (2013)
• Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
  di: Vollebergh, Marieke A, et al.
  Pubblicazione: (2014)
• Identification of BRCA1-like triple-negative breast cancers by quantitative multiplex-ligation-dependent probe amplification (MLPA) analysis of BRCA1-associated chromosomal regions: a validation study
  di: Gross, Eva, et al.
  Pubblicazione: (2016)
• Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response
  di: Lips, Esther H., et al.
  Pubblicazione: (2015)